BUND FINANCE

BUND FINANCE › Stocks › COR

Cencora, Inc. (COR)

NYSE · Stock price, chart and technical analysis

US$348.31-2.25 (-0.64%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$350.56
OpenUS$347.16
Day rangeUS$344.49 – US$349.80
52-week rangeUS$244.82 – US$377.54
Market capUS$66.47B
Volume1.20M
50-day averageUS$328.20
200-day averageUS$316.64
Beta0.58
Last dividend per shareUS$2.46

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20222023202420252026
RevenueUS$238.6BUS$262.2BUS$294.0BUS$321.3BUS$337.4B
Net incomeUS$1.7BUS$1.7BUS$1.5BUS$1.6BUS$3.5B
EPS (diluted)8.048.537.537.9617.95
Gross margin3.2%3.0%3.0%3.2%4.1%
Operating margin1.2%0.9%1.0%1.1%1.2%
Net margin0.7%0.7%0.5%0.5%1.0%
Free cash flowUS$2.2BUS$3.5BUS$3.0BUS$3.2BUS$3.9B
Total debtUS$7.6BUS$6.8BUS$6.7BUS$9.3BUS$11.3B
CashUS$3.5BUS$2.7BUS$3.2BUS$4.4BUS$4.9B

Compound annual growth: revenue 9.1% · net income 19.7% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E19.4x24.5x27.1x
EV / EBITDA11.8x12.9x16.5x
Operating margin1.3%—3.6%
Net margin1.0%—-0.0%
Debt / equity22.66—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About Cencora, Inc.

SectorHealthcare
IndustryMedical - Distribution
CountryUS
CEORobert Mauch
Employees49,000
IPO date1995-04-04

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products l…

www.cencora.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice